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The composition of the early immune repertoire is biased with prominent expression of
spontaneously arising B cell clones that produce IgM with recurrent and often autoreactive
binding speciﬁcities. Amongst these naturally arising antibodies (NAbs) are IgM antibodies
that speciﬁcally recognized amaged and senescent cells, often via oxidation-associated
neo-determinants. These NAbs are present from birth and can be further boosted by
apoptotic cell challenge. Recent studies have shown that IgM NAb to apoptotic cells can
enhance phagocytic clearance, as well as suppress proinﬂammatory responses induced
via Toll-like receptors, and block pathogenic IgG-immune complex (IC)-mediated inﬂam-
matory responses. Speciﬁc antibody effector functions appear to be involved, as these
anti-inﬂammatory properties are dependent on IgM-mediated recruitment of the early
recognition factors of complement. Clinical surveys have suggested that anti-apoptotic
cell (AC) IgM NAbs may modulate disease activity in some patients with autoimmune
disease. In mechanistic studies, anti-AC NAbs were shown to act in dendritic cells by
inhibition of the mitogen-activated protein kinase (MAPK) pathway, a primary signal trans-
duction pathway that controls inﬂammatory responses. This immunomodulatory pathway
has an absolute requirement for the induction of MAPK phosphatase-1. Taken together,
recent studies have elucidated the novel properties of a class of protective NAbs, which
may directly blunt inﬂammatory responses through a primitive pathway for regulation of
the innate immune system.
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INTRODUCTION
The evolutionary emergence of the combinatorial antigen receptor
system of variable region (V) gene rearrangements in lymphocytes
has provided a greatly enhanced capacity for speciﬁc recogni-
tion of an immense range of ligands. In humans, the antibody
system can generate B cell antigen receptors (BCR) encoded by
more than 1020 genetically distinct variable region rearrange-
ments. Considering that each individual has only about 1011
lymphocytes, if the primary B cell repertoire was indeed generated
randomly, there would belittle or no recurrence in the antibody
gene sequences in the somatically generated repertoires of the bil-
lions of humans on the planet. In the following sections, we review
evidence the B cell compartment arises during development with
a restricted and biased repertoire, and that the antibody prod-
ucts of these B cell clones may serve to protect the host from
both external threats and for the maintenance of internal home-
ostasis.
RESTRICTION IN THE EARLY REPERTOIRE
In themouse, there is a remarkable restriction in the usage patterns
of the heavy chain V region (VH) genes during early repertoire
development (Perlmutter et al., 1985). Surveys of murine antibody
sequences have provided extensive evidence of recurrent lympho-
cyte clones with the same V gene rearrangements in different
individuals (Seidl et al., 1997), and emerging data suggests there
may be similar patterns in the human B cell repertoire (Jackson
et al., 2012). In fact, these biases in the expression of VH rearrange-
ments are ﬁrst detectable at a time point at which representation
cannot be affected by antigenic selection of these IgM-associated
clones (Schroeder et al., 1987; Schroeder and Wang, 1990). More-
over, a recent report suggested that the perinatal VH repertoire
expressed in human IgA may be even more restricted than the
IgMpool (Rogosch et al., 2012). Recurrent biases in theVH expres-
sion in the early B cell repertoire have also been reported in other
species, such as swine (Sun et al., 1998) and sheep (Jenne et al.,
2006), as well as more primitive species, such as the amphibian
Xenopus laevis (Flajnik and Rumfelt, 2000), and zebraﬁsh (Du
Pasquier et al., 2000).
Both humans and mice have circulating IgM antibodies that
arise early life without immunogenic challenge and have there-
fore been termed natural antibodies (NAbs). In fact, neonatal
B cells produce IgM antibodies that are readily detectable in
the bloodstream at birth, and studies in mice have shown that
more than 80% of circulating IgM are produced by a pheno-
typically distinct mature B cell subset, termed the B-1a cell
subset, and characterized by membrane-associated CD5. In gen-
eral, while someB-1 cells express antigen-receptors for recognition
of common bacterial Ags, some B-1 cell clones can also recog-
nize self-antigens, including thephospholipidphosphatidylcholine
(PtC), the phospholipid-associated phosphorylcholine (PC) head
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group, as well as DNA and certain cell membrane proteins (Kantor
and Herzenberg, 1993).
B-1 cells are believed to represent a developmentally distinct
lineage from their adult counterpart, the bone marrow-derived
B-2 subset (reviewed in Hardy, 2006; Baumgarth, 2011). Murine
B-1 clones are self-replenishing, which ensures the maintenance
of this repertoire, as later in life the capacity for de novo genera-
tion of mature lymphocytes with the B-1 cell phenotype is limited.
Studies by Notkins and colleagues have shown that CD5-bearing
human B cells also have a bias toward the production of certain
types of autoantibodies (Casali andNotkins, 1989). However, CD5
molecules can represent an activation marker on human B cells,
and hence by itself CD5 may not be a rigorous phenotypic marker
for this B cell subset in humans (Cong et al., 1991). To address
this long standing issue, Rothstein and coworkers have reported a
detailed phenotyping scheme, in addition to CD5, for identifying
human B cells with the diagnostic features of B-1 cells. The reper-
toire of these human B-1 cells also appeared to include prominent
expression of self-speciﬁcities for native DNA and PC-containing
antigens (Grifﬁn et al., 2011).
AUTOREACTIVITY OF B LYMPHOCYTE SUBSETS
In mice, mature B-1 and B-2 lymphocyte subsets can play discrete
but complementary functional roles in host defenses (reviewed
in Baumgarth, 2011). There are also subpopulations within B-1
cells in addition to CD5+ B-1a cells, as B-1b cells (that do not
express CD5) make essential contributions to T cell-independent
defenses for certain types of infections (Alugupalli and Abraham,
2009). The clonal selection of these distinct B cell subsets may
in part reﬂect differences in their cellular thresholds for negative
selection (i.e., BCR-induced cell death) and in their activation
requirements for second signals after BCR stimulation. By one
estimate, over 70% of BCR-expressing immature B cells in the
bone marrow display some level of autoreactivity while the level
is much less in recirculating naïve mature B-2 cells (Wardemann
et al., 2003). Hence, the immune tolerance checkpoints for B-2
cells that arise from precursors in the bone marrow appear to be
generally more stringent in the removal of self-reactivity (i.e., neg-
ative selection). In contrast, conserved B-1 cell clonotypes may be
positively selected (i.e., enhanced survival and clonal proliferation)
by certain types of non-protein self-antigens (Hayakawa et al.,
1999), which may include speciﬁc types of intracellular antigens
(Ferry et al., 2007). As B-1 cells are a major source of circulating
IgM in neonates, this may explain why neonatal IgM–NAbs from
umbilical cord commonly display features of self-reactivity (Chou
et al., 2009).
In the human immune system there is a remarkably strong
association between the immune recognition of cell surface
N-acetyllactosamine/polylactosamine determinants in glyco-
conjugates and the usage of the VH4-34 gene segment
(originally termed VH4-21; Silberstein et al., 1991). N-ace-
tyllactosamine/polylactosamine moieties are common on cell sur-
faces throughout the body, as these are structural components
of the I/i blood group antigens and also constitute the antigenic
target of pathogenic autoantibodies in cold-agglutinin disease
(Silverman et al., 1990; Silberstein et al., 1991; Grillot-Courvalin
et al., 1992; Pascual and Capra, 1992).
The immune recognition of I/i related non-protein antigens
may be involved in very different types of immune responses.
Using a lectin microarray system, exosomes released by human
tumor cell lines were shown to express a shared polylactosamine
glycan signature (Batista et al., 2011). These ﬁndings extend ear-
lier evidence that I/i related determinants can be preferentially
expressed on cells during early development and on their malig-
nant counterparts (i.e., onco-fetal antigens; Feizi, 1988). In addi-
tion, VH4-34 encoded autoantibodies were found to commonly
bind to HIV-1 envelope determinants (Kobie et al., 2012). Batista
et al. (2011) have suggested that these glycans reﬂect a recurrent
type of glycan epitope proﬁle on stressed and apoptotic cells (ACs).
Taken together, these ﬁndings highlight the intertwined nature
of immunodominant determinants on microparticles, exosomes,
and HIV-1 virions that arise by budding through the membranes
of stressed host cells.
B cell receptor encoded by VH4-34 rearrangements recognize
I/i determinants via contact sites associated with a VH germline
framework subdomain sequences – there is little apparent contri-
bution from the somatically generated heavy chain CDR3 or by
the paired light chain (Pascual et al., 1991). Using the 9G4 anti-
idiotype antibody, B cells that bear non-mutatedVH4-34 products
have been shown to be highly represented, and whereas in healthy
individuals these autoreactive germline B cells were shown to be
excluded from T cell-dependent germinal center reactions (Pugh-
Bernard et al., 2001), these VH deﬁned clones can be actively
recruited into the germinal center reactions in patients with sys-
temic lupus erythematosus (SLE; Cappione et al., 2005). These
ﬁndings have been interpreted as evidence of immune defects
in SLE patients related to the regulation of autoreactive B cells,
although this topic remains controversial.
NATURAL ANTIBODIES AND IMMUNE RECOGNITION OF
DAMAGED AND APOPTOTIC CELLS
During the process of AC death, different cell membrane-
associated phospholipids can undergo selective enzyme-mediated
and oxidation associated modiﬁcations, and these cell mem-
brane neo-determinants become available for recognition by the
immune system. Among these, phosphatidylserine (PS) becomes
oxidized and rapidly translocates from the inner to the outer leaﬂet
of the cell membrane upon the initiation of apoptosis, where it can
serve as a recognition signal for ingestion by professional phago-
cytes (i.e., “eat me” signal). Apoptosis can also be associated with
other lipid neo-determinants, such as malondialdehyde (MDA),
which is formed from interactions of unsaturated lipids with reac-
tive oxidation species. Oxidative modiﬁcations of the abundantly
distributed neutral phospholipid, PtC, also affect the distribu-
tion and/or conformation of the PC head group (Friedman et al.,
2002), which renders it accessible for antibody recognition. These
PC-antigens, as well as MDA-containing antigens, are immun-
odominant within murine B cell clonal responses that are boosted
by intravenous infusions of ACs (Chen et al., 2009b).
The dominant natural antibody-producing anti-PC B cell
clone, termed T15 (also TEPC15), has recurrently been isolated
in anti-PC responses. The high representation of this clone in
the early repertoire in part reﬂects a bias for increased represen-
tation of the speciﬁc VHS107.1 gene rearrangements used by the
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T15 clone (Feeney, 1991). In fact both of the VH and VL rear-
rangements in the T15 clone are formed by primary sequence
direct rearrangements, and are without somatic mutations. The
invariance of the T15 clonotypic NAb therefore is reminiscent of
germline encoded receptors of the innate immune system (dis-
cussed in Shaw et al., 2000). In fact, T15 clonotypic antibodies are
highly speciﬁc for PC determinants (Kearney et al., 1981) and in
microarray analysis demonstrated little or no cross-reactivity to a
large number of structurally distinct antigens (Chen et al., 2009b).
Throughout life, T15-related B-1 cells are a major source of NAbs
to a range of PC-containing antigens (Masmoudi et al., 1990),
including those present on AC membranes, oxidized low-density
lipoprotein (LDL), as well as in pneumococcal bacterial cell wall
polysaccharide (Shaw et al., 2003; Chou et al., 2009). Many other
B-1 cell clones have been demonstrated to be polyreactive and
relatively low-afﬁnity (Kantor and Herzenberg, 1993). However,
crystallographic analysis of aVHS107.1 encoded (i.e., T15-related)
Fab revealed a deep antigen-binding cleft with substantial bind-
ing afﬁnity for the small PC moiety (reviewed in Davies et al.,
1975). As a consequence of the dependence of the in vivo anti-PC
response on T15 clonotypic B cells, otherwise immunocompe-
tent mice which were made deﬁcient only for the S107.1 VH gene
segment, have highly impaired responses to immune challenge
with PC determinants on either ACs or bacteria, and also dis-
play impaired immune defenses for S. pneumoniae infection (Mi
et al., 2000; Chen et al., 2009b). Taken together, these studies sug-
gest that the antigen binding sites of T15-related antibodies have
innate-like properties for recognition of PC-containing antigens
are highly represented in the pre-immune repertoire (Kearney,
2005), in part because of their preferentially formation by biases
in the somatic diversiﬁcation mechanisms (Feeney, 1992).
Within the NAb pool there are also other antibodies that
recognize distinct sets of neo-determinants that arise following
cellular injury. There are at least two self-antigen speciﬁcities that
have been reported to be associated with post-ischemic injury of
endothelial cells (Zhang et al., 2008; Kulik et al., 2009). In addition,
there are IgM–NAbs that speciﬁcally recognize erythrocytes with
cellmembrane-associated changes due to senescence or fromdam-
age by experimental treatment with the protease, bromalein (Cox
and Hardy, 1985; Mercolino et al., 1986; Hardy and Hayakawa,
2005). These antibodies are reported to recognize a determinant
involving PtC, although it is unclear whether the accessibility of
this PtC-associated red cell epitope results from oxidative modiﬁ-
cation, or due to loss of erythrocyte membrane proteins. Red cell
membrane intrinsic proteins have also been implicated as anti-
genic targets for IgG–NAbs (Lutz, 2012). Notably, as red cells
have neither mitochondria nor nuclei, these cells do not undergo
the same apoptosis-associated metabolic changes seen in con-
ventional mitochondria-containing cells. This may explain why
PC-related antigens are not prominently displayed on erythro-
cytes as a consequence of aging. Taken together, the cumulative
data suggest that the IgM repertoire may include a range of
distinct subsets of autoreactive NAbs, which recognize differ-
ent cell types affected by apoptosis, injury and senescence, and
these NAbs may help to regulate the clearance of different cell
types and tissue remodeling as well as modulate innate immune
responses.
EFFECTS OF PC-SPECIFIC NATURAL IgM ON TOLL-LIKE
RECEPTOR-INDUCED INFLAMMATION
Earlier studies have shown that C1q can directly binding to AC
membranes and then serve as an“eat-me”signal for the phagocytic
clearance of these dying cells (Korb and Ahearn, 1997; Navratil
et al., 2001; Ogden et al., 2001). In explanation, C1q may directly
interactwith externalizedPSon these damaged cells (Paidassi et al.,
2008). In some settings, the deposition of C1q ontoACs can subse-
quently have an immunomodulatory effect and inhibit the secre-
tion of proinﬂammatory cytokines, although by itself these effects
are limited (Fraser et al., 2009). Similar properties have also been
associated with the mannose-binding lectin (MBL),which triggers
the lectin pathway of complement activation. MBL is structurally
related to C1q and these two recognition molecules share a com-
mon ancestral genetic origin (Matsushita et al., 2004). Further-
more,MBL can also binddirectly toACs. Thismay suggest that ini-
tiation of apoptosis is associated with a change in the distribution
of high-mannose glycoconjugates on the cell membrane (Stuart
et al., 2005). These ﬁndings are consistent with reports that phago-
cytes of C1q-deﬁcient mice, as well as MBL-deﬁcient mice, display
defects in AC clearance (Quartier et al., 2005; Stuart et al., 2005).
The potential roles of T15 IgM–NAb have been investigated
in the innate immune responses of professional phagocytes. As
mentioned above, while this IgM natural antibody does not bind
healthy cells it can speciﬁcally recognize exposed PC determi-
nants on ACs and form complexes (Chen et al., 2009a,b). In turn,
theseAC–IgM complexes have greatly enhanced capacity to recruit
the early complement factors, C1q and the structurally related
MBL, at levels several-fold higher than in the absence of bound
IgM. Notably the recruitment of C1q or MBL by IgM–NAb com-
plexes greatly ampliﬁes the capacity for AC phagocytic clearance
(Chen et al., 2009a,b; illustrated in Figure 1). These properties are
explained by reports that some polymeric IgM, when bound to
their cognate antigen, are highly efﬁcient at recruitment of C1q,
while other studies have shown that polymeric IgM themselves
can contain high mannose glycoconjugates (Arnold et al., 2006).
Hence, AC-reactive polymeric IgM may serve to integrate these
complement associated innate immune functions (Quartier et al.,
2005; Chen et al., 2009a,b).
The formation of IgM–NAb complexes with ACs can also
result in strong suppression of in vivo and in vitro inﬂamma-
tory responses, including those induced by ligands for both
membrane-associated and endosomal Toll-like receptors (TLRs),
which include TLR3, TLR4, TLR7, and TLR9 (Chen et al., 2009b).
These activities are also dependent on the recruitment of C1q and
MBL,which are postulated to serve as bridgingmolecules that trig-
ger phagocyte functions in a way that does not require activation
of the complement cascade (Chen et al., 2009a,b). Hence, both the
enhancement of apoptotic clearance and the down-modulation
of inﬂammatory responses are therefore pathways by which some
NAbsmay augment and amplify housekeeping functions that serve
to protect the host.
EFFECTS OF THE APOPTOTIC CELL-SPECIFIC NAb–IgM ON
IMMUNE COMPLEX DRIVEN PATHOGENESIS
During autoimmune pathogenesis high-afﬁnity IgG autoanti-
bodies can make direct contributions by multiple mechanisms
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FIGURE 1 | Model of an IgM–NAb complex that enhances interactions
between an apoptotic cell and professional phagocytes. In this idealized
model, apoptotic death results in membrane alterations that expose a range
of neo-determinants. PC-associated membrane determinants are recognized
by antigen-binding sites of a pentameric IgM. Binding of PC determinants
results in conformational changes in the mu constant regions, which expose a
conformational site responsible for recruitment of the globular heads of C1q
(Czajkowsky and Shao, 2009). Alternatively, MBL binds to nearby high
mannose N-linked glycoconjugates on mu-associated sites (not shown). This
polymeric IgM–C1q complex is involved in generating or stabilizing
interactions with receptors on professional phagocytes, which enhance
apoptotic phagocytosis and blocks inﬂammatory responses.
(reviewed in Elkon and Casali, 2008; Lleo et al., 2010). Central to
these pathways, many IgG autoantibodies implicated in systemic
autoimmune diseases form immune complexes (ICs) with their
target antigen, which alter their potential interactions with the
host immune system. In sera of patients with conditions such as
SLE and Sjogren’s syndrome, nucleic acid-recognizing autoanti-
bodies can form ICs with their antigens, ribonucleoproteins, or
deoxyribonucleoproteins. These ICs can deposit in tissues such as
the kidney, skin, and joints and drive local inﬂammation and tissue
injury by triggering complement cascades (reviewed in Bagavant
and Fu, 2009). IgG-ICs might additionally serve as a delivery sys-
tem to transport self-antigens to endosomal pattern-recognition
receptors (PRRs) via uptake by activating Fc receptors. Studies
by Marshak-Rothstein, Rifkin, and Rönnblom have demonstrated
that DNA or RNA-containing ICs consisting of IgG autoantibod-
ies bound to nuclear debris from dying cells can activate mouse
B cells (Leadbetter et al., 2002), conventional dendritic cells (DCs;
Boulé et al., 2004), and plasmacytoid DCs (Yasuda et al., 2007)
as well as human peripheral blood mononuclear cells (Lövgren
et al., 2004). These IgG-nucleic acid ICs can interact with rheuma-
toid factor autoantibody-bearing B cells (Leadbetter et al., 2002)
or with DCs bearing activating FcγR,which enables the delivery to
otherwise inaccessible intracellular compartments. The outcome
of this targetedDNA/RNA internalization is the activation of PRRs
of the innate immune system, such as the nucleic acid-recognizing
TLRs; TLR7 (activated by ssRNA) and TLR8 and TLR9 (activated
by DNA). IgG antibodies to the citrullinated self-protein, ﬁbrino-
gen, which are prevalent in rheumatoid arthritis patients, have
also been shown in vitro to activate macrophages through a co-
stimulatory pathway involving both FcγR and TLR4 (Sokolove
et al., 2011).
The pathogenic inﬂuence of IgG autoantibody-ICs can be
opposed by IgM natural antibodies to ACs. In vivo studies have
shown that administration of anti-PC natural IgM greatly atten-
uated disease severity in a murine model of collagen-induced
arthritis (CIA; Chen et al., 2009a). In this model, immuniza-
tion with xenogenic collagen II emulsiﬁed in complete Freund’s
adjuvant induces a pathogenic autoimmune response to type II
collagen (Terato et al., 1992; Nandakumar et al., 2003), with tis-
sue injury in part mediated through the activating Fc-γ receptors
(Kleinau et al., 2000). Infusions of IgM–NAbs to ACs also blocked
the disease process induced by passive transfer of anti-type II col-
lagen autoantibodies (Chen et al., 2009a), in which inﬂammatory
arthritis is mediated by FcγR and innate immune cells, while lym-
phocytes do not play central roles (Terato et al., 1992; Nandakumar
et al., 2003).
In vitro studies have shown that anti-AC IgM antibodies can
directly block the activating effects of lupus-associated IgGautoan-
tibodies on bone marrow-derived DCs (Vas et al., 2012). In fact,
the inﬂammatory effects of both anti-DNA and -RNA IgG-nucleic
acid ICs in myeloid DCs were inhibited with suppression of the
secretion of inﬂammatory cytokines IL-6 and TNF-α (Vas et al.,
2012). This IgM–NAb also suppressed IC-mediated induction of
cell surface expression of CD80 and CD86, as well as CD40 and
other co-stimulatory molecules.
NATURAL ANTIBODY REGULATORY PATHWAYS THAT
MODULATE INFLAMMATORY AND AUTOIMMUNE DISEASES
Serologic surveys of a large cohort of well-characterized SLE
patients have further evaluated the potential clinical relevance
of IgM autoantibodies to deﬁned oxidation-associated antigenic-
speciﬁcities, including the apoptosis-associated neo-antigens, PC
and MDA. In the lupus cohort, levels of both of these types of
IgM autoantibodies were signiﬁcantly higher compared to healthy
adult controls (Grönwall et al., 2012a). Importantly, higher levels
of IgM anti-PC correlated with less long-term organ damage, as
deﬁned by the SLICC/ACR damage index score, as well as lower
disease activity as assessed by the SELENA revision of the SLE
disease activity index (SLEDAI) at the time of visit. IgM anti-
PC levels also correlated with an absence of cardiovascular events,
while therewere no associationswith renal disease (Grönwall et al.,
2012a). These results are consistent with a previous report from a
smaller cohort of Swedishpatients (Su et al., 2008) andwith studies
showing that lower IgM anti-PC levels are associated with more
frequent cardiovascular events in non-autoimmune patients (de
Faire et al., 2010; Fiskesund et al., 2010). These ﬁndingswere in fact
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predicted by earlier studies in atherosclerosis-prone mice (Shaw
et al., 2000). Indeed, pneumococcal vaccination, which induces
PC-speciﬁc antibody responses, was shown to arrest plaque pro-
gression inLDL receptor-deﬁcientmicewith cholesterol levels over
1000 mg/dl (Binder et al., 2003). These ﬁndings have therefore fur-
ther strengthened the hypothesis that some anti-AC IgM–NAbs
can play protective roles in inﬂammatory disease.
Yet not every IgM–NAb that recognizes ACs may have equiv-
alent clinical implications. In fact, levels of antibodies to PC and
to MDA showed signiﬁcant differences in their associations with
lupus clinical manifestations. IgM anti-MDA showed only weak
inverse correlations with the SLICC/ACR damage index but not
the SELENA-SLEDAI score and there were also no signiﬁcant
associations with renal disease or cardiovascular events (Grön-
wall et al., 2012a). These studies also showed that higher levels of
the IgM antibody to β2-GPI correlated with less organ damage by
SLICC/ACR damage index. Furthermore, patients without renal
disease had higher levels of IgM anti-CL, and IgM anti-dsDNA
(Grönwall et al., 2012a). This may indicate that higher levels of
some IgM antibodies may protect some patients from kidney dis-
ease, as suggested in an earlier and more focused report (Mehrani
and Petri, 2011). Taken together, these studies refute the notion
that circulating IgM autoantibodies are inherently polyreactive.
Instead, these data strongly argue that the antigenic ﬁne binding
speciﬁcity of the IgM determines whether there is an associa-
tion with protection from certain lupus disease features (Grönwall
et al., 2012a). In a recent clinical study, Ajeganova et al. (2011)
examinedRApatients treatedwithTNF-αblockers. They observed
that levels of PC-speciﬁc natural IgM levels were increased in
patients treated with TNF-α blockade, while lower anti-PC IgM
levels correlated with inferior response to therapeutic interven-
tion for RA disease. Further investigations will be needed to better
understand how anti-AC NAbs may modulate the pathogenesis of
different autoimmune rheumatic diseases.
MAPK PHOSPHATASE-1 IS REQUIRED FOR NATURAL
ANTIBODY SUPPRESSION OF TLR RESPONSES
Investigations of signal transduction pathways have shown that
IgM–NAbs to ACs can affect responses induced by agonists for
a broad range of TLRs, by inhibition of the mitogen-activated
protein kinase (MAPK) signal transduction system, which plays
central roles in the induction and resolution of inﬂammatory
responses (Grönwall et al., 2012b). Inﬂammatory responses can
result from the induction of phosphorylation of one ormore of the
primary MAPKs; ERK1/2, JNK, and particularly p38, which then
translocate to the nucleus where it can affect transcriptional reg-
ulation. In rheumatoid arthritis, activated (phosphorylated) p38
is increased in the RA synovium. However, despite evidence that
small molecule p38 inhibitors have been effective in mouse mod-
els of inﬂammatory arthritis, efﬁcacy in humans has been limited,
which has suggested that an alternate approach to MAPK inhibi-
tion may provide greater clinical beneﬁts (reviewed in Hammaker
and Firestein, 2010).
To assess the potential relevance of this type of immunomod-
ulatory NAb to clinical autoimmune diseases, the activity of the
PC-speciﬁc IgM–NAb was also tested in a system in which inﬂam-
matory responses are induced by lupus IgG autoantibodies (Vas
et al., 2012). These studies demonstrated that this natural IgM
inhibited p38 phosphorylation induced in DCs by nucleic acid-
containing IgG autoantibody ICs (Vas et al., 2012). Notably, this
inhibitory pathway also blocked the nuclear accumulation of the
activated primary MAPKs in myeloid DCs (Vas et al., 2012). In
vitro studies of murine bone marrow-derived DCs conﬁrmed
that this inhibition was entirely dependent on the recruitment
of either C1q or MBL (Grönwall et al., 2012b; illustrated in
Figure 1).
The magnitude and duration of MAPK signaling is dependent
on the balance between the upstream activators of the system
and the deactivation of these kinases by speciﬁc phosphatases.
Based on evidence that this NAb could affect the activation of
each of the three primary MAPKs (Grönwall et al., 2012b), studies
were therefore performed that assessed the potential involvement
of the regulatory MAPK phosphatases (MKPs), also known as
dual-speciﬁcity phosphatases (DUSPs). These studies highlighted
the role of MKP-1, the archetype for the family, which can
serve as the counter-regulatory factor for all three of the pri-
mary MAPKs (reviewed in Liu et al., 2007). In fact, the anti-AC
IgM-mediated blockade of TLR-mediated MAPK signaling had
an absolute requirement for the expression of MKP-1 (Grönwall
et al., 2012b). In DCs activated by TLR agonists, the addition
of the anti-AC IgM, in the presence of C1q or MBL in serum-
free media, resulted in induction within minutes of MKP-1 at
a transcript and a protein level, and it rapidly became localized
within the nucleus (Grönwall et al., 2012b). Using deconvolu-
tional immunoﬂuorescence microscopy, NAb-mediated MKP-1
accumulation correlatedwith a reciprocal impairment in the phos-
phorylation and nuclear translocation of the activated primary
MAPK protein molecules. To investigate the relative contribution
of MKP-1 to NAb-mediated suppression, responses were com-
pared in DCs from wild-type or MKP-1-deﬁcient mice (Grönwall
et al., 2012b). Such MKP-1-deﬁcient mice are reported to exhibit
overexuberant inﬂammatory responses, but no other immune
developmental abnormalities (Dorfman et al., 1996; Salojin et al.,
2006). These studies conﬁrmed the absolute requirement for
MKP-1 for IgM–NAb-mediated inhibition of TLR responses from
DCs (Grönwall et al., 2012b).
CONCLUDING REMARKS
One of the most fundamental challenges faced by the immune
system is the efﬁcient recognition and clearance of the body’s own
cells, which because of senescence or injury enter programmed cell
death pathways. While cells dying of apoptotic death pathways do
not pose an immediate risk to the host, if these cell corpses are not
efﬁciently removed there is the risk of progression to secondary
necrosis. This can lead to the loss of integrity of cell membranes
with release of cytoplasmic and nuclear components that can serve
as ligands for proinﬂammatory cellular receptors, and the trigger-
ing of autoimmune responses. Hence, throughout the lifespan of
multicellular organisms, there is an absolute need for the clearance
of the immense number of cell corpses that are generated each
day, even in health. As a direct consequence, the immune system
has developed a redundant layering of superimposedmechanisms.
Hence, the control of apoptotic clearance is intertwined with the
regulation and resolution of inﬂammatory responses.
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At birth, humans already have substantial levels of circulating
IgM antibodies, which reﬂect a functional B cell compartment
poised and ready to contribute to neonatal host defenses. These
IgM antibodies arise in the womb from neonatal B lympho-
cytes that express clonally distributed BCRs. However, evidence
of recurrent clones suggests that this early B cell repertoire may
be affected by in vivo clonal selection that may be a response to
evolutionary pressure to provide important housekeeping func-
tions related to apoptotic clearance and avoidance of excessive and
damaging inﬂammatory responses.
IgM-mediated protection from autoimmune disease was ﬁrst
demonstrated in mice deﬁcient in the capacity to secrete IgM
antibodies, as these mice were found to develop pathologic
autoimmunity with the production of lupus IgG autoantibodies
(Boes et al., 2000; Ehrenstein et al., 2000). Furthermore, in mice
predisposed to the development of lupus-like disease, a bias toward
secretion of monomeric IgM and lower levels of polymeric IgM
can result in accelerated development of lupus-like disease (Youd
et al., 2004). It may therefore be relevant that 8% of a cohort of 300
SLE patients were recently reported to have selective deﬁciency in
serum IgM (Perrazio et al., 2012).
Our studies demonstrated that anti-AC IgM–NAbs, present
from early in life, can suppress inﬂammatory responses mediated
by phagocytic cells by induction of MKP-1, which in other settings
have been shown to have potent regulatory roles for theMAPK sys-
tem. MKP-1 is well known for its many counter-regulatory roles,
which include the late negative feedback of responses to LPS stim-
ulation, the blunting of responses after rapid re-exposure to a
TLR agonist such as LPS tolerance, as well as contributing to the
anti-inﬂammatory properties of glucocorticoids (reviewed in Liu
et al., 2007). These studies also documented an additive effect of
anti-AC IgM–NAb and dexamethasone for early MKP-1 induc-
tion and inhibition of LPS-induced p38 MAPK activation that,
when combined, exceeded the maximum effects of either agent
alone (Grönwall et al., 2012b). In part, this is likely explained by
the additive integration of separate signals received via distinct cell
membrane-associated receptors triggered by dexamethasone (i.e.,
glucocorticoid receptor) or by anti-AC IgM complexes (discussed
below). As glucocorticoids are amongst the most widely pre-
scribed treatments for inﬂammatory and autoimmune diseases,
it is indeed intriguing that there is an overlap in the inhibitory sig-
nal transduction pathways of glucocorticoids and by the formation
of regulatory ICs with early complement recognition factors that
are coordinated in their organization by IgM autoantibodies to
oxidation-associated neo-determinants on ACs.
Fundamental to the inhibitory effects of regulatory NAbs, poly-
meric IgMs that bind ACs can express constant regions with
multiple sites for recruitment of C1q, and the Fcμ of some IgM–
NAbs also have high mannose glycoconjugates on that bind MBL
(Chen et al., 2009a,b). The potential properties of such com-
plexes suggested by studies with targeted deﬁciencies in C1q,
MBL, or secreted IgM, which each have impaired control of
inﬂammatory responses, and in some cases are predisposed to
the development of autoimmune disease (Botto et al., 1998; Boes
et al., 2000; Ehrenstein et al., 2000; Stuart et al., 2005). Further-
more, we have previously shown that the complement-dependent
immunomodulatory properties of anti-AC IgM,while the recruit-
ment of C1q or MBL was essential, there was no absolute require-
ment for downstreamactivationof the complement cascade (Chen
et al., 2009a).
These IgM–NAbs to AC-associated determinants can regulate
responses mediated by diverse TLRs, an ancient type of innate
immune receptor that was ﬁrst characterized in insects (Lemaitre
et al., 1996). Furthermore, mechanistic investigations have shown
these effects are linked to modulation of the MAPK signaling sys-
tem,which is one of the earliest evolutionarily conserved pathways
of immunity, being present in plants and mammals (Asai et al.,
2002). Likewise, MKP-1 orthologs have also been described in
protozoans (Moncho-Amor et al., 2011), and as mentioned above,
mice with MKP-1 deﬁciency have severe defects in the control of
innate responses (Salojin et al., 2006). These regulatory proper-
ties are expressed by a class of naturally occurring autoreactive
antibodies that are postulated to come from the most primitive
tier of B cells in the adaptive immune system (Kantor and
Herzenberg, 1993).
As ACs are ubiquitous, we wonder whether the high frequency
of these innate-like NAb-producing clones in the “preimmune”
repertoire in part reﬂects positive selection of the B-1 cell clones
that are reactive with membrane-associated neo-determinants on
cells wasted during development. The protective properties of
anti-AC NAbs may be mediated by a previously unknown reg-
ulatory signaling pathway, which integrates and coordinates the
inﬂuence of select innate immune factors onmyeloid cell function.
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